, Australia

nib postpones increasing health insurance premiums for Australians

The insurer will postpone the increase until 1 November.

Australian healthcare insurer nib has announced that it will again postpone increasing health insurance premiums for its Australian Residents Health Insurance (ARHI) members for an additional two months until 1 November 2022 to further support members impacted by the COVID-19 pandemic.

The premium increase was approved last 1 April but the insurer decided to postpone the increase for five months. The approved increase, averaging 2.66%, is the insurer’s lowest premium increase in 20 years. The announcement brings the premium postponement to seven months.

The postponement will apply to all nib ARHI members who hold an active policy between 1 April 2022 and 31 October 2022. Members who held an active policy as at 31 March 2022 but become no longer active between 1 July 2022 and 31 October 2022 will be eligible for a pro-rata give back instead.

nib said will notify eligible members of the premium postponement with the changes automatically applied to their health cover policy.

You may also like:

Australia life insurance industry suffers 88.6% loss in investment revenues

Prudential hires ex-Citi banker as new group chief

India’s Digit Insurance eyes $500m IPO

Follow the link for more news on

Prudential, StanChart memperkuat 25 Tahun kemitraan bancassurance

Mereka memiliki kemitraan bancassurance terlama di Singapura dan Asia.

MSIG Asia dan RiskPoint mempertaruhkan asuransi energi terbarukan

Kawasan Asia-Pasifik berpotensi menarik investasi sebesar $3 triliun dalam pembangkitan listrik hingga 2033.

Kantor pusat Pru Life UK di Manila menerapkan kerja hibrida

Kantor ini memiliki area rekreasi dan kesehatan untuk membantu karyawan menyegarkan diri.

Etiqa meluncurkan produk asuransi takaful pertama di Singapura

Permintaan terhadap produk keuangan Islam dari Timur Tengah dan Asia Tenggara terus meningkat.

Perusahaan asuransi jiwa Singapura bidik pertumbuhan di 2025

Dorongan untuk solusi layanan kesehatan inovatif di tengah inflasi medis menjadi tantangan.